The TSH‐CAR‐T cells demonstrate effective antitumor activity against TSHR‐positive differentiated thyroid cancer (DTC) cell lines in vitro, accompanied by cytokine release (IFNγ, IL‐2) and robust proliferation. This evidence concerns the gene IFNG and thyroid gland carcinoma.